STOCK TITAN

Bullfrog AI Holdings, Inc. Warrants 10-Q Filings

BFRGW NASDAQ

Every 10-Q that Bullfrog AI Holdings, Inc. Warrants (BFRGW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow BFRGW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BFRGW filings page.

Rhea-AI Summary

BullFrog AI Holdings, Inc. reported minimal early-stage revenue and continuing losses for the six months ended June 30, 2026 while raising significant equity to extend its runway. Collaboration revenue was $215,385, all from a new feasibility agreement with a global pharmaceutical company, producing gross profit of $106,899.

Operating expenses were $3.1 million, mainly research and development of $774,275 and general and administrative costs of $2.37 million, leading to a net loss of $2,964,691. Operating cash use was $3.21 million. The company offset this through financings, receiving $7.85 million net from common stock sales under its at-the-market program and equity line, ending with cash and restricted cash of about $7.0 million and stockholders’ equity of $6,987,262.

Management states this cash is not sufficient to fund planned operations for 12 months, and the filing notes substantial doubt about the ability to continue as a going concern. BullFrog AI also discloses noncompliance with Nasdaq’s $1.00 minimum bid-price requirement and a one-year panel monitoring period following recent stockholders’ equity noncompliance, with potential reverse stock split authority already approved.

Rhea-AI Summary

BullFrog AI Holdings, Inc. reported a Q1 2026 net loss of $1.59 million, improving from a $2.02 million net loss a year earlier as operating expenses declined to $1.61 million. The company generated no revenue in either period, so results reflect primarily research and administrative spending.

Cash and restricted cash totaled $5.19 million at March 31, 2026, up from $2.29 million at year-end, mainly from equity financing. BullFrog raised roughly $4.46 million net through its at-the-market program and equity line, increasing common shares outstanding to 18.45 million and lifting stockholders’ equity to $4.89 million. Management still notes substantial doubt about the company’s ability to continue as a going concern and highlights Nasdaq minimum bid-price compliance risk.

Rhea-AI Summary

Bullfrog AI Holdings, Inc. reported a first commercial collaboration payment and recognized $33,257 of revenue in the quarter, producing a small gross profit of $6,522. The company recorded a net loss of $1,448,729 for the three months and $3,466,282 for the six months ended June 30, 2025, and has an accumulated deficit of approximately $20.3 million. Total assets fell to $2.87 million and stockholders' equity declined to $2.19 million.

Liquidity is constrained: cash and cash equivalents were approximately $2.6 million (including about $0.1 million restricted cash) and the company discloses that this is not sufficient to fund planned operations for at least a year, raising substantial doubt about its ability to continue as a going concern. Management is pursuing additional capital through equity, debt, licensing and collaborations and has used an ATM facility, raising $346,000 in June 2025 and subsequently gross proceeds of about $710,000 after the quarter.

Operationally, Bullfrog AI continues to commercialize its bfLEAP™ AI/ML platform under exclusive licenses with research institutions including JHU-APL, which carries tiered royalties and minimum annual payments. Management also discloses unremediated material weaknesses in internal controls and ongoing remediation efforts.